Active	Status	Sponsor type	Region	Phase	Filter
16 Active 34 Inactive 50 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Park, Ji Yeon
NCT05573815: Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images	Recruiting	N/A	558	RoW	BT-M01	Heuron Inc.	Brain Metastases	11/22	12/22
NCT05716672: Impact of Lazertinib Dose Modification on Effectiveness and Safety	Not yet recruiting	N/A	200	RoW	Lazertinib, LECLAZA	Pusan National University Hospital, Yuhan Corporation	Non-small Cell Lung Cancer	12/25	12/25
Park, Ji-Young
NCT04676893: Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects	Not yet recruiting	1	56	RoW	D418 Tab., Reference, CKD-388 Tab., Test	Chong Kun Dang Pharmaceutical	Chronic Hepatitis b	05/21	05/21
NCT05544214: Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects	Completed	1	32	RoW	CKD-371, D745, D759	Chong Kun Dang Pharmaceutical	Type II Diabetes Mellitus	11/22	11/22